메뉴 건너뛰기




Volumn 126, Issue 5, 2004, Pages 1680-1682

Is Dressler syndrome dead?

Author keywords

Inflammatory reaction; Myocardial necrosis; Pericardial effusion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

EID: 8744314893     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.5.1680     Document Type: Article
Times cited : (43)

References (31)
  • 1
    • 77049317231 scopus 로고
    • A post-myocardial infarction syndrome: Preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis
    • Dressler W. A post-myocardial infarction syndrome: preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. JAMA 1956; 160:1379-1383
    • (1956) JAMA , vol.160 , pp. 1379-1383
    • Dressler, W.1
  • 2
    • 70449235780 scopus 로고
    • The post-myocardial infarction syndrome
    • Dressler W. The post-myocardial infarction syndrome. Arch Intern Med 1959; 103:28-42
    • (1959) Arch Intern Med , vol.103 , pp. 28-42
    • Dressler, W.1
  • 4
    • 0020644699 scopus 로고
    • Characteristics, prevalence, and prognosis of postmyocardial infarction syndrome
    • Welin L, Vedin A, Wilhelmsson C. Characteristics, prevalence, and prognosis of postmyocardial infarction syndrome. Br Heart J 1983; 50:140-145
    • (1983) Br Heart J , vol.50 , pp. 140-145
    • Welin, L.1    Vedin, A.2    Wilhelmsson, C.3
  • 5
    • 0021332439 scopus 로고
    • Evidence for the continued existence of the postmyocardial infarction (Dressler's) syndrome
    • Northcote RJ, Hutchison SJ, McGuinness JB. Evidence for the continued existence of the postmyocardial infarction (Dressler's) syndrome. Am J Cardiol 1984; 53:1201-1202
    • (1984) Am J Cardiol , vol.53 , pp. 1201-1202
    • Northcote, R.J.1    Hutchison, S.J.2    McGuinness, J.B.3
  • 6
    • 0027424433 scopus 로고
    • The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
    • GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-1622
    • (1993) N Engl J Med , vol.329 , pp. 1615-1622
  • 7
    • 0032574633 scopus 로고    scopus 로고
    • Extended mortality benefit of early postinfarction reperfusion: GUSTO-I Angiographic Investigators; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial
    • Ross AM, Coyne KS, Moreyra E, et al. Extended mortality benefit of early postinfarction reperfusion: GUSTO-I Angiographic Investigators; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial. Circulation 1998; 97:1549-1556
    • (1998) Circulation , vol.97 , pp. 1549-1556
    • Ross, A.M.1    Coyne, K.S.2    Moreyra, E.3
  • 8
    • 0037187893 scopus 로고    scopus 로고
    • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
    • Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346:957-966
    • (2002) N Engl J Med , vol.346 , pp. 957-966
    • Stone, G.W.1    Grines, C.L.2    Cox, D.A.3
  • 9
    • 0027931119 scopus 로고
    • Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis
    • Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology 1994; 85:255-258
    • (1994) Cardiology , vol.85 , pp. 255-258
    • Shahar, A.1    Hod, H.2    Barabash, G.M.3
  • 10
    • 0020454850 scopus 로고
    • Current incidence of postmyocardial infarction (Dressler's) syndrome
    • Lichstein E, Arsura E, Hollander G, et al. Current incidence of postmyocardial infarction (Dressler's) syndrome. Am J Cardiol 1982; 50:1269-1271
    • (1982) Am J Cardiol , vol.50 , pp. 1269-1271
    • Lichstein, E.1    Arsura, E.2    Hollander, G.3
  • 11
    • 0015230058 scopus 로고
    • Pericarditis after acute myocardial infarction
    • Thadani U, Chopra MP, Aber CP, et al. Pericarditis after acute myocardial infarction. BMJ 1971; 2:135-137
    • (1971) BMJ , vol.2 , pp. 135-137
    • Thadani, U.1    Chopra, M.P.2    Aber, C.P.3
  • 12
    • 0022003064 scopus 로고
    • Complement activation after myocardial infarction
    • Earis JE, Marcuson EC, Bernstein A. Complement activation after myocardial infarction. Chest 1985; 87:186-190
    • (1985) Chest , vol.87 , pp. 186-190
    • Earis, J.E.1    Marcuson, E.C.2    Bernstein, A.3
  • 13
    • 0019867733 scopus 로고
    • Reappraisal of the postmyocardial infarction Dressler's syndrome
    • Kossowsky WA, Lyon AF, Spain DM. Reappraisal of the postmyocardial infarction Dressler's syndrome. Am Heart J 1981; 102:954-956
    • (1981) Am Heart J , vol.102 , pp. 954-956
    • Kossowsky, W.A.1    Lyon, A.F.2    Spain, D.M.3
  • 14
    • 0021259538 scopus 로고
    • Left ventricular mural thrombi complicating acute myocardial infarction: Long-term follow-up with serial echocardiography
    • Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction: long-term follow-up with serial echocardiography. Ann Intern Med 1984; 100:789-794
    • (1984) Ann Intern Med , vol.100 , pp. 789-794
    • Weinreich, D.J.1    Burke, J.F.2    Pauletto, F.J.3
  • 15
    • 0027161727 scopus 로고
    • Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)
    • Correale E, Maggioni AP, Romano S, et al. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI). Am J Cardiol 1993; 71:1377-1381
    • (1993) Am J Cardiol , vol.71 , pp. 1377-1381
    • Correale, E.1    Maggioni, A.P.2    Romano, S.3
  • 16
    • 0028144938 scopus 로고
    • Effect of definition on incidence of postinfarction pericarditis: It is time to redefine postinfarction pericarditis?
    • Oliva PB, Hammill SC, Talano JV. Effect of definition on incidence of postinfarction pericarditis: it is time to redefine postinfarction pericarditis? Circulation 1994; 90:1537-1541
    • (1994) Circulation , vol.90 , pp. 1537-1541
    • Oliva, P.B.1    Hammill, S.C.2    Talano, J.V.3
  • 17
    • 0016141089 scopus 로고
    • Soluble-complex formation after myocardial infarction
    • Versey JM, Gabriel R. Soluble-complex formation after myocardial infarction. Lancet 1974; 2:493-494
    • (1974) Lancet , vol.2 , pp. 493-494
    • Versey, J.M.1    Gabriel, R.2
  • 18
    • 0026665361 scopus 로고
    • ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts
    • Linz W, Wiemer G, Scholkens BA. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol 1992; 24:909-919
    • (1992) J Mol Cell Cardiol , vol.24 , pp. 909-919
    • Linz, W.1    Wiemer, G.2    Scholkens, B.A.3
  • 19
    • 0033406821 scopus 로고    scopus 로고
    • Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
    • Gullestad L, Aukrust P, Ueland T, et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999; 34:2061-2067
    • (1999) J Am Coll Cardiol , vol.34 , pp. 2061-2067
    • Gullestad, L.1    Aukrust, P.2    Ueland, T.3
  • 20
    • 0034595362 scopus 로고    scopus 로고
    • Beta-adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
    • Prabhu SD, Chandrasekar B, Murray DR, et al. Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000; 101:2103-2109
    • (2000) Circulation , vol.101 , pp. 2103-2109
    • Prabhu, S.D.1    Chandrasekar, B.2    Murray, D.R.3
  • 21
    • 0034533147 scopus 로고    scopus 로고
    • Statins as a newly recognized type of immunomodulator
    • Kwak B, Mulhaupt F, Myit S, et al. Statins as a newly recognized type of immunomodulator. Nat Med 2000; 6:1399-1402
    • (2000) Nat Med , vol.6 , pp. 1399-1402
    • Kwak, B.1    Mulhaupt, F.2    Myit, S.3
  • 22
    • 0035133351 scopus 로고    scopus 로고
    • Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy
    • Ohtsuka T, Hamada M, Hiasa G, et al. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001; 37:412-417
    • (2001) J Am Coll Cardiol , vol.37 , pp. 412-417
    • Ohtsuka, T.1    Hamada, M.2    Hiasa, G.3
  • 23
    • 0029157002 scopus 로고
    • Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
    • Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92:748-755
    • (1995) Circulation , vol.92 , pp. 748-755
    • Neumann, F.J.1    Ott, I.2    Gawaz, M.3
  • 24
    • 0034704893 scopus 로고    scopus 로고
    • C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    • Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843
    • (2000) N Engl J Med , vol.342 , pp. 836-843
    • Ridker, P.M.1    Hennekens, C.H.2    Buring, J.E.3
  • 25
    • 0035963529 scopus 로고    scopus 로고
    • Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
    • Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-1965
    • (2001) N Engl J Med , vol.344 , pp. 1959-1965
    • Ridker, P.M.1    Rifai, N.2    Clearfield, M.3
  • 26
    • 0037134842 scopus 로고    scopus 로고
    • Systemic inflammation in unstable angina is the result of myocardial necrosis
    • Cusack MR, Marber MS, Lambiase PD, et al. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39:1917-1923
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1917-1923
    • Cusack, M.R.1    Marber, M.S.2    Lambiase, P.D.3
  • 27
    • 0037093893 scopus 로고    scopus 로고
    • Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia
    • Kinlay S, Timms T, Clark M, et al. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. Am J Cardiol 2002; 89:1205-1207
    • (2002) Am J Cardiol , vol.89 , pp. 1205-1207
    • Kinlay, S.1    Timms, T.2    Clark, M.3
  • 28
    • 0035804846 scopus 로고    scopus 로고
    • Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
    • Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285:1711-1718
    • (2001) JAMA , vol.285 , pp. 1711-1718
    • Schwartz, G.G.1    Olsson, A.G.2    Ezekowitz, M.D.3
  • 29
    • 0036239382 scopus 로고    scopus 로고
    • Early initiation of treatment with statins in acute coronary syndromes
    • Olsson AG, Schwartz GG. Early initiation of treatment with statins in acute coronary syndromes. Ann Med 2002; 34:37-41
    • (2002) Ann Med , vol.34 , pp. 37-41
    • Olsson, A.G.1    Schwartz, G.G.2
  • 30
    • 0035806626 scopus 로고    scopus 로고
    • Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study
    • Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001; 286:64-70
    • (2001) JAMA , vol.286 , pp. 64-70
    • Albert, M.A.1    Danielson, E.2    Rifai, N.3
  • 31
    • 0037032276 scopus 로고    scopus 로고
    • Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: An experimental serial cardiac magnetic resonance imaging study
    • Nahrendorf M, Hu K, Hiller KH, et al. Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. J Am Coll Cardiol 2002; 40:1695-1700
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1695-1700
    • Nahrendorf, M.1    Hu, K.2    Hiller, K.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.